These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 10734508

  • 1. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia.
    Van Riet FA, Wessels G, Hesseling PB.
    East Afr Med J; 1999 Oct; 76(10):571-4. PubMed ID: 10734508
    [Abstract] [Full Text] [Related]

  • 2. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 3. Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura.
    Stasi R, Brunetti M, Pagano A, Stipa E, Masi M, Amadori S.
    Blood Cells Mol Dis; 2000 Dec; 26(6):582-6. PubMed ID: 11112391
    [Abstract] [Full Text] [Related]

  • 4. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS.
    Acta Haematol; 2006 Dec; 115(1-2):46-52. PubMed ID: 16424649
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E, Aslan Y, Gedik Y, Orhan F.
    Turk J Pediatr; 2003 Dec; 45(4):295-300. PubMed ID: 14768792
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
    Tamminga R, Berchtold W, Bruin M, Buchanan GR, Kühne T.
    Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
    [Abstract] [Full Text] [Related]

  • 9. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
    Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G.
    N Engl J Med; 2003 Aug 28; 349(9):831-6. PubMed ID: 12944568
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A, Kovaleva L, Loria S, Alberca I, Hernandez F, Sandoval V, Sierra J, Vidaller A, Ayguasanosa J, Carretero M.
    Transfus Med; 2009 Oct 28; 19(5):260-8. PubMed ID: 19747289
    [Abstract] [Full Text] [Related]

  • 11. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy.
    Andersen JC.
    N Engl J Med; 1994 Jun 02; 330(22):1560-4. PubMed ID: 8177245
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life.
    Lowe EJ, Buchanan GR.
    J Pediatr; 2002 Aug 02; 141(2):253-8. PubMed ID: 12183723
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
    Pugina SA, Evdokimova NM, Rastorguev GG, Samoĭlova OS, Sorokina IV, Sidnev GV, Vasil'ev DM, Anastasiev VV, Milovidova OV, Molodovskaia EV, Borovkov NN.
    Ter Arkh; 1999 Aug 02; 71(8):50-4. PubMed ID: 10515038
    [Abstract] [Full Text] [Related]

  • 16. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
    Hedlund-Treutiger I, Henter JI, Elinder G.
    J Pediatr Hematol Oncol; 2003 Feb 02; 25(2):139-44. PubMed ID: 12571466
    [Abstract] [Full Text] [Related]

  • 17. The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients.
    Szczepanik AB, Sikorska A, Slomkowski M, Konopka L.
    Int J Lab Hematol; 2007 Oct 02; 29(5):347-51. PubMed ID: 17824915
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M, Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto.
    Haematologica; 2005 Jan 02; 90(1):72-7. PubMed ID: 15642672
    [Abstract] [Full Text] [Related]

  • 19. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS, Carcao M.
    Semin Thromb Hemost; 2003 Dec 02; 29(6):605-17. PubMed ID: 14719177
    [Abstract] [Full Text] [Related]

  • 20. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.
    Dickerhoff R, von Ruecker A.
    J Pediatr; 2000 Nov 02; 137(5):629-32. PubMed ID: 11060527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.